FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
Canaccord analyst Mark Massaro is defending T2 Biosystems (NASDAQ: TTOO) by saying buy on weakness. Analyst comments: "Shares of T2 Biosystems are down 15% on a short report that appears on Seeking Alpha. As we previewed this morning, T2 is set to... More
White Diamond Research negatived on T2 Biosystems (NASDAQ: TTOO), sets $1.50 price target (LINK)

